Mito-TEMPO, a Mitochondria-Targeted Antioxidant, Improves Cognitive Dysfunction due to Hypoglycemia: an Association with Reduced Pericyte Loss and Blood-Brain Barrier Leakage
Authors:
- 11 November 2022
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 60 (2) , 672-686
Abstract
Hypoglycemia is associated with cognitive dysfunction, but the exact mechanisms have not been elucidated. Our previous study found that severe hypoglycemia could lead to cognitive dysfunction in a type 1 diabetes (T1D) mouse model. Thus, the aim of this study was to further investigate whether the mechanism of severe hypoglycemia leading to cognitive dysfunction is related to oxidative stress-mediated pericyte loss and blood-brain barrier (BBB) leakage. A streptozotocin T1D model (150 mg/kg, one-time intraperitoneal injection), using male C57BL/6J mice, was used to induce hypoglycemia. Brain tissue was extracted to examine for neuronal damage, permeability of BBB was investigated through Evans blue staining and electron microscopy, reactive oxygen species and adenosine triphosphate in brain tissue were assayed, and the functional changes of pericytes were determined. Cognitive function was tested using Morris water maze. Also, an in vitro glucose deprivation model was constructed. The results showed that BBB leakage after hypoglycemia is associated with excessive activation of oxidative stress and mitochondrial dysfunction due to glucose deprivation/reperfusion. Interventions using the mitochondria-targeted antioxidant Mito-TEMPO in both in vivo and in vitro models reduced mitochondrial oxidative stress, decreased pericyte loss and apoptosis, and attenuated BBB leakage and neuronal damage, ultimately leading to improved cognitive function.Keywords
All Related Versions
This publication has 46 references indexed in Scilit:
- Glucagon-Like Peptide 1 Reduces Endothelial Dysfunction, Inflammation, and Oxidative Stress Induced by Both Hyperglycemia and Hypoglycemia in Type 1 DiabetesDiabetes Care, 2013
- Topiramate Treatment Protects Blood-Brain Barrier Pericytes from Hyperglycemia-Induced Oxidative Damage in Diabetic MiceEndocrinology, 2012
- Pharmacologic amelioration of severe hypoglycemia-induced neuronal damageNeuroscience Letters, 2011
- Reversal of preexisting hyperglycemia in diabetic mice by acute deletion of the Men1 geneProceedings of the National Academy of Sciences, 2010
- Melatonin reduces experimental subarachnoid hemorrhage‐induced oxidative brain damage and neurological symptomsJournal of Pineal Research, 2009
- Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signalingThe FASEB Journal, 2007
- Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidaseJournal of Clinical Investigation, 2007
- S-Nitrosylation of Matrix Metalloproteinases: Signaling Pathway to Neuronal Cell DeathScience, 2002
- The problem of assessing effective neuroprotection in experimental cerebral ischemiaProgress in Neurobiology, 1998
- Hypoglycemic Brain Injury in the Rat: Correlation of Density of Brain Damage with the EEG Isoelectric Time: A Quantitative StudyDiabetes, 1984